Fixed dose combination dextromethorphan-bupropion: A hope for treatment resistant depression (TRD)
Background: Treatment resistant depression (TRD) has been identified as non-response to depression with adequate dose and trial of two antidepressant medications of different classes. Near about 30% depressive patients are TRD cases. Olanzapine‐fluoxetine combination, rTMS, Intravenous ketamine and...
Saved in:
| Main Authors: | Ranjan Das, Rajarshi Chakravarty, Varaha V. Gantait, Subir Bhattacharjee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Series: | Indian Journal of Psychiatry |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/indianjpsychiatry_315_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of dextromethorphan-bupropion exposures compared with exposures involving dextromethorphan alone or bupropion alone reported to United States poison centers
by: Sonia Ngo, et al.
Published: (2025-12-01) -
Improvement of depressive symptoms, after a suicide attempt, with dextromethorphan/bupropion combination treatment in a patient with treatment‐resistant depression and psychiatric comorbidities
by: Bruno Pedraz‐Petrozzi, et al.
Published: (2023-03-01) -
Can dextromethorphan-bupropion reduce mental pain in depressed individuals? A hypothesis-generating overview perspective
by: Maurizio Pompili, et al.
Published: (2025-03-01) -
Sustainable spectrophotometric determination of dextromethorphan and bupropion: A fourier self-deconvolution approach
by: Fotouh R. Mansour, et al.
Published: (2025-06-01) -
SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile
by: Ying Xiao, et al.
Published: (2024-09-01)